BR9913490A - Prosaposina cìclicos e seus usos - Google Patents

Prosaposina cìclicos e seus usos

Info

Publication number
BR9913490A
BR9913490A BR9913490-0A BR9913490A BR9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A
Authority
BR
Brazil
Prior art keywords
cyclic
prosaposine
derived
peptides
saposin
Prior art date
Application number
BR9913490-0A
Other languages
English (en)
Portuguese (pt)
Inventor
David E Wright
John
S O'obrien
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of BR9913490A publication Critical patent/BR9913490A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
BR9913490-0A 1998-08-28 1999-08-20 Prosaposina cìclicos e seus usos BR9913490A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Publications (1)

Publication Number Publication Date
BR9913490A true BR9913490A (pt) 2001-09-25

Family

ID=22268937

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913490-0A BR9913490A (pt) 1998-08-28 1999-08-20 Prosaposina cìclicos e seus usos

Country Status (13)

Country Link
EP (1) EP1105420A1 (hu)
JP (2) JP4528443B2 (hu)
KR (1) KR20010079695A (hu)
CN (1) CN1324367A (hu)
AU (1) AU751034B2 (hu)
BR (1) BR9913490A (hu)
CA (1) CA2341810A1 (hu)
CZ (1) CZ2001655A3 (hu)
HU (1) HUP0103265A3 (hu)
IL (1) IL141586A0 (hu)
PL (1) PL204359B1 (hu)
WO (1) WO2000012553A1 (hu)
ZA (1) ZA200102489B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
CA2341810A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
WO2007127439A2 (en) 2006-04-28 2007-11-08 Children's Hospital Medical Center Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
CN101541307A (zh) * 2006-10-20 2009-09-23 儿童医院医疗中心 自发形成的椭圆体磷脂单层囊泡
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
EP3285735B1 (en) 2015-04-23 2021-06-23 The Procter & Gamble Company Delivery of surfactant soluble anti-dandruff agent
EP3423031B1 (en) 2016-03-03 2021-09-08 The Procter & Gamble Company Aerosol antidandruff composition
CN109843252A (zh) 2016-10-21 2019-06-04 宝洁公司 指定毛发体积有益效果的浓缩型洗发剂泡沫剂型
US10888505B2 (en) 2016-10-21 2021-01-12 The Procter And Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
EP3528894A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
EP3528898A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair conditioning benefits
CN109789076A (zh) 2016-10-21 2019-05-21 宝洁公司 具有低粘度和粘度降低剂的稳定致密洗发剂产品
CN109843381A (zh) 2016-10-21 2019-06-04 宝洁公司 用于提供毛发护理有益效果的浓缩型洗发剂泡沫剂型
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
CN111201010A (zh) 2017-10-10 2020-05-26 宝洁公司 用呈泡沫形式的个人护理组合物处理毛发或皮肤的方法
EP4400092A3 (en) 2017-10-10 2024-10-16 The Procter & Gamble Company Compact shampoo composition with amino acid based anionic surfactants and cationic polymers
US11116703B2 (en) 2017-10-10 2021-09-14 The Procter And Gamble Company Compact shampoo composition containing sulfate-free surfactants
JP2020536885A (ja) 2017-10-10 2020-12-17 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 無機塩低含有の、サルフェートを含まないパーソナルクレンジング組成物
MX2020005900A (es) 2017-12-20 2022-03-31 Procter & Gamble Composicion de champu clara que contiene polimeros de silicona.
US11318073B2 (en) 2018-06-29 2022-05-03 The Procter And Gamble Company Low surfactant aerosol antidandruff composition
WO2021113583A1 (en) 2019-12-06 2021-06-10 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
WO2021173203A1 (en) 2020-02-27 2021-09-02 The Procter & Gamble Company Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics
CN116568263A (zh) 2020-12-04 2023-08-08 宝洁公司 包含恶臭减少材料的毛发护理组合物
US20220378684A1 (en) 2021-05-14 2022-12-01 The Procter & Gamble Company Shampoo Compositions Containing a Sulfate-Free Surfactant System and Sclerotium Gum Thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
CA2341810A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof

Also Published As

Publication number Publication date
CN1324367A (zh) 2001-11-28
IL141586A0 (en) 2002-03-10
HUP0103265A2 (hu) 2002-02-28
PL346346A1 (en) 2002-02-11
CA2341810A1 (en) 2000-03-09
HUP0103265A3 (en) 2002-09-30
JP2010150272A (ja) 2010-07-08
JP2002523518A (ja) 2002-07-30
EP1105420A1 (en) 2001-06-13
JP4528443B2 (ja) 2010-08-18
PL204359B1 (pl) 2010-01-29
AU751034B2 (en) 2002-08-08
CZ2001655A3 (cs) 2001-11-14
ZA200102489B (en) 2002-06-04
AU5690599A (en) 2000-03-21
WO2000012553A1 (en) 2000-03-09
KR20010079695A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
BR9913490A (pt) Prosaposina cìclicos e seus usos
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
EP0624348A3 (en) Bipolar electrosurgical instruments.
DE69927956D1 (de) Shampoo zusammensetzungen auf basis von silikon
FI955866A (fi) Poishuuhdeltavat vesi öljyssä vedessä -koostumukset
MA25279A1 (fr) Compositions rafraichissantes.
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
DE69210683D1 (de) Endoskopische, bipolare elektrochirurgische Instrumente
BR0109943A (pt) Composições farmacêuticas
ES2081870T3 (es) Composiciones polipropilenicas plasto-elasticas.
PT817847E (pt) Receptor de il-17
MX9206423A (es) Composicion de perfume.
DE69730092D1 (de) Photovernetzbare Siliconzusammensetzungen
DE69723277D1 (de) Dampfsterilisierungsanzeigdende zusammensetzungen
DE69300694D1 (de) Desinfizierende Zusammensetzungen.
DE59401899D1 (de) Längenverstellbare Säule für Stühle, Tische o.dgl.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
ITTO930346A0 (it) Procedimento per la preparazione di derivati taurocolanici.
MX9204623A (es) Compuesto de bis-4-piperidil-fosfita n-metilada.
IT1303736B1 (it) Peptidi derivati da rantes con attivita' anti-hiv.
TR199601012A2 (tr) Sampuan terkibi.
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
DK0977871T3 (da) Neurotrypsin
PT633928E (pt) Microrganismos processo de preparacao e utilizacao

Legal Events

Date Code Title Description
PC Transfer

Free format text: MYLS ACQUISITIONS CORP (US)

TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.